Cleared Traditional

K222852 - Nipro SafeTouch Needle

Also marketed or referenced as:
Nipro Syringe with SafeTouch Needle

K222852 is an FDA 510(k) clearance for Nipro SafeTouch Needle, manufactured by Nipro Medical Corporation. The device is a Class 2 General Hospital device with product code FMI cleared through the Traditional 510(k) pathway after a 246-day FDA review.

K222852 · Nipro Medical Corporation · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 2023
Decision
246d
Days
Class 2
Risk

K222852 is an FDA 510(k) clearance for the Nipro SafeTouch Needle. Classified as Needle, Hypodermic, Single Lumen (product code FMI), Class II - Special Controls.

Submitted by Nipro Medical Corporation (Miami, US). The FDA issued a Cleared decision on May 25, 2023 after a review of 246 days - an extended review cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5570 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General Hospital review framework, consistent with the majority of Class II 510(k) submissions.

View all Nipro Medical Corporation devices

FDA 510(k) Submission Details - K222852

510(k) Number K222852 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 21, 2022
Decision Date May 25, 2023
Days to Decision 246 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
117d slower than avg
Panel avg: 129d · This submission: 246d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

FMI Device Classification - Class 2, Special Controls

Product Code FMI Needle, Hypodermic, Single Lumen
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5570
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - FMI Needle, Hypodermic, Single Lumen

All 454
Devices cleared under the same product code (FMI) and FDA review panel - the closest regulatory comparables to K222852.
Altaviz Needle Kit II
K231261 · Altaviz, LLC · Jul 2023
EZ-IO Intraosseous Vascular Access System
K231924 · Teleflex Medical · Jul 2023
Pen Needle
K230635 · Jiangsu Caina Medical Co.,Ltd · Jun 2023
Disposable Insulin Pen Needle
K222739 · Hantech Medical Device Co., Ltd. · Apr 2023
Shina Safety Needle
K222417 · Shina Corporation · Mar 2023
Sterile Aesthetic Cannula and Hypodermic Needle
K223327 · Shanghai Kindly Enterprise Development Group Co., Ltd. · Feb 2023